The funding will allow Deep 6 AI to better meet the demand of healthcare provider, pharmaceutical company and research organization clients for its suite of clinical trial-optimizing AI tools. The startup will also further refine those tools and expand its network of clients, which currently includes Cedars-Sinai Medical Center in Los Angeles and Houston-based Texas Medical Center, among several other health systems, life sciences companies, devicemakers and research facilities.
The Pasadena, Calif.-based company, which was founded in 2015, is an alumnus of several accelerator programs, including Texas Medical Center’s TMCx in early 2018 and Stanford (Calif.) University’s now-defunct StartX in the fall of 2016, the latter of which provided Deep 6 AI with approximately $600,000 in seed funding and other resources.
More articles on AI:
Human-AI collaboration more effective than either working alone: Stanford study
AI predicts seizures 1 hour before onset with 99.6% accuracy, study finds
Novartis launches program with Biofourmis for AI monitoring of heart failure patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
